Literature DB >> 11211940

Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells.

B Fernandez Pujol1, F C Lucibello, M Zuzarte, P Lütjens, R Müller, K Havemann.   

Abstract

CD14-positive monocytes obtained from human peripheral blood were cultured with GM-CSF and IL-4. During the early culture phase immature dendritic cells (DCs) developed which not only expressed CD1a, HLA-DR and CD86, but also expressed the endothelial cell markers von Willebrand factor (vWF), VE-cadherin and VEGF receptors Flt-1 and Flt-4. Further maturation of DCs was achieved by prolonged cultivation with TNFalpha. These cells showed typical DC morphology and like professional antigen-presenting cells (APCs) expressed CD83 and high levels of HLA-DR and CD86. However, if immature DCs were grown with VEGF, bFGF and IGF-1 on fibronectin/vitronectin-coated culture dishes, a marked change in morphology into caudated or oval cells occurred. In the presence of these angiogenic growth factors the cultured cells developed into endothelial-like cells (ELCs), characterized by increased expression of vWF, KDR and Flt-4 and a disappearance of CD1a and CD83. Addition of IL-4 and Oncostatin M also increased VE-cadherin expression, and the loosely adherent cells formed clusters, cobblestones and network-like structures. vWF- expressing ELCs mainly originated from CD1a-positive cells, and VEGF was responsible for the decrease in the expression of the DC markers CD1a and CD83. In mixed leukocyte cultures, mature DCs were more potent APCs than ELCs. Moreover, Ac-LDL uptake, and the formation of tubular structures on a plasma matrix was restricted to ELCs. These results suggest that in the presence of specific cytokines immature DCs have the potential to differentiate along different lineages, i.e. into a cell type resembling ELCs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11211940     DOI: 10.1078/0171-9335-00136

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  30 in total

1.  Mesenchymal stem cell (MSC) and endothelial progenitor cell (EPC) growth and adhesion in six different bone graft substitutes.

Authors:  J Schultheiss; C Seebach; D Henrich; K Wilhelm; J H Barker; J Frank
Journal:  Eur J Trauma Emerg Surg       Date:  2011-06-07       Impact factor: 3.693

2.  Monocytes form a vascular barrier and participate in vessel repair after brain injury.

Authors:  John Glod; David Kobiler; Martha Noel; Rajeth Koneru; Shoshana Lehrer; Daniel Medina; Dragan Maric; Howard A Fine
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

3.  Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response.

Authors:  Randall J Smith; Tai Yi; Bita Nasiri; Christopher K Breuer; Stelios T Andreadis
Journal:  FASEB J       Date:  2019-01-10       Impact factor: 5.191

4.  The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.

Authors:  Leslee Sprague; Maria Muccioli; Michelle Pate; Evan Meles; John McGinty; Harika Nandigam; Amritha K Venkatesh; Ming-Yu Gu; Kristen Mansfield; Andrew Rutowski; Omowaleola Omosebi; Maria C Courreges; Fabian Benencia
Journal:  BMC Immunol       Date:  2011-06-06       Impact factor: 3.615

Review 5.  Pattern response of dendritic cells in the tumor microenvironment and breast cancer.

Authors:  Alessandra da Cunha; Marcia A Michelin; Eddie Fc Murta
Journal:  World J Clin Oncol       Date:  2014-08-10

6.  Role of dendritic cells in cardiovascular diseases.

Authors:  Yi Zhang; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-11-26

Review 7.  Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors.

Authors:  Sara Mariucci; Bianca Rovati; Mariangela Manzoni; Matteo Giovanni Della Porta; Giuditta Comolli; Sara Delfanti; Marco Danova
Journal:  Clin Exp Med       Date:  2010-12-16       Impact factor: 3.984

8.  Adhesion to substrates induces dendritic cell endothelization and decreases immunological response.

Authors:  Jacob Osterbur; Leslee Sprague; Maria Muccioli; Michelle Pate; Kristen Mansfield; John McGinty; Yihan Li; Yandi Li; Venktesh Shirure; Maria Cecilia Courreges; Fabian Benencia
Journal:  Immunobiology       Date:  2012-02-27       Impact factor: 3.144

9.  Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions.

Authors:  Gianni Gerlini; Adrian Tun-Kyi; Christa Dudli; Günter Burg; Nicola Pimpinelli; Frank O Nestle
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer.

Authors:  Heather L Pulaski; Gregory Spahlinger; Ines A Silva; Karen McLean; Angela S Kueck; R Kevin Reynolds; George Coukos; Jose R Conejo-Garcia; Ronald J Buckanovich
Journal:  J Transl Med       Date:  2009-06-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.